Cargando…
Supporting the use of a coagulometric method for rivaroxaban control: a hypothesis-generating study to define the safety cut-offs
AIMS: Although quantitative anti-FXa assays can be used to measure rivaroxaban plasma levels, they are not widely performed or available. We aimed to tentatively determine the cut-off for thromboembolism and bleeding prevention based on the clotting effect of non-rivaroxaban conjugate-activated FX p...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527354/ https://www.ncbi.nlm.nih.gov/pubmed/26251639 http://dx.doi.org/10.1186/s12959-015-0058-9 |